FTO and acute myeloid leukemia: In this study, R-2HG was used to directly inhibit FTO in R-2HG-sensitive acute myeloid leukemia and glioma cells, leading to increased methylation and decreased expression of c-MYC and CEBPA mRNAs, thereby enhancing the anti-tumor effects.